Today Indian stock market has faced down position of the morning time. Indian stock market has closed on the down position. Their Mumbai Stock market (BSE) sensex has closed 480 points down and National stock market (NSE) of Nifty is below 123 points.  Mumbai Stock market (BSE) Medium and small share index is fall of around two per cent.  International Stock Market - U.S. market stock has also closed on the worries position, their stock position is not good. It also is facing down position. Their U.S. market share Dao Jones at 348 and NASDAQ closed down 92 points.

Read the rest of this entry »

The market has lost further grounds on account of huge selling pressure continued in the selective scrips. The broader market is trading flat today as the Mid Cap is trading marginally lower while the Small Cap managed to trade in green. The Capital Goods, Oil & Gas, Bank and IT stocks are out of favor today while the sustained buying is seen in the Metal, FMCG and Realty stocks. The overall market breadth turns negative, as 1219 stocks are advancing while 1299 stocks are declining and the 57 stocks remained unchanged on BSE.

The BSE Mid cap is lower by 40 points at 6,231 while the BSE small Cap advanced by 12 points to trade at 7,451.

At 12.30 pm, BSE Sensex was at 15,899 down by 188 points and Nifty was at 4,789.90 down by 38.95 points.

BSE Metal index inclined by 17.05 points to trade at 13,762.23. The major gainers are Gujarat NRE (6.35%), Hindalco Industries (5.07%), NALCO (4.02%) and Bhusan Steel (1.10%).

BSE Capital goods index dropped by 172.84 points to 13,621.20. The main losers are Siemens (2.75%), BEML (2.48%), Bharat Electrical (1.91%) and Havells India (2.70%).

BSE Banks index slipped by 147.69 points to trade at 8,154.11. The top losers are AXIX Bank (3.70%), Bank of India (2.92%), Yes Bank (1.65%) and HDFC Bank (1.54%).

BSE Health Care index inclined marginally by 0.75 points to trade at 3,738.26 as Sun Pharma (2.52%), Cipla (1.58%), Lupin (1.29%), Glaxosmith (1.90%) and Pfizer (0.43%) are trading in positive.

Sun pharmaceuticals has received the USFDA approval for the abbreviated new drug application to market a generic version of forest Lab’s Tessalon, benzonatate capsules.

Cipla has developed a combination of drugs including the medicines for allergic rhinitis, asthama and cardiac-problems for the developed markets. The company expects to bring the allergic rhinitis drug into the market next year and the other two combination drugs in the asthama and cardiac are expected by 2010.

[Via]

United Phosphorus Ltd has informed that the Board of Directors of the Company at its meeting held on December 20, 2007, the Board has approved the Scheme of Arrangement fortransfer of Haldia Division of SWAL Corporation Ltd (100% subsidiary of the Company) with the Company……………………….

The scheme shall be subject to necessary approvals and sanctions of the Honourable High Court of Judicature at Mumbai and Honourable High Court of Gujarat at Ahmedabad………………….

Read More: ragadirect.com

HMT Ltd has announced the following Unaudited results for the quarter ended September 30, 2007:

The Company has posted a net loss after tax of Rs 32.40 million for the quarter ended September 30, 2007 as compared to net profit of Rs 880.90 million for the quarter ended September 30, 2006. Total Income has decreased from Rs 739.60 million for the quarter ended September 30, 2006 to Rs 680.50 million for the quarter ended September 30, 2007.Buy at current market price Rs.86 for three month target of Rs.100.

They are reported in batter excellent Stock Result in last quarter ended.Today this company is best position so I am say Stock and Stock Market price will be increased.